Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08 - Wikidata - wikimedia - TriplyDB

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

http://www.wikidata.org/entity/Q30374740

about

The ambiguous base-pairing and high substrate efficiency of T-705 (Favipiravir) Ribofuranosyl 5'-triphosphate towards influenza A virus polymerase Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression Systematic review of influenza resistance to the neuraminidase inhibitors Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance Pandemic potential of a strain of influenza A (H1N1): early findings Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors Safety and efficacy of peramivir for influenza treatment Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be established H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets Can we "hedge" against the development of antiviral resistance among pandemic influenza viruses?Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages Drug resistance in influenza A virus: the epidemiology and management.Tracking oseltamivir-resistance in New Zealand influenza viruses during a medicine reclassification in 2007, a resistant-virus importation in 2008 and the 2009 pandemic.In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus.Continuing challenges in influenza.Strain-specific antiviral activity of iminosugars against human influenza A viruses Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007-08.Zanamivir-resistant influenza viruses with a novel neuraminidase mutation Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance.Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China.Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo Experiments Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.The anti-tumor agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), induces IFN-beta-mediated antiviral activity in vitro and in vivo.Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico.A severely immunocompromised child with uncomplicated oseltamivir-resistant 2009 H1N1 pandemic influenza infection.Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferrets Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective.Oseltamivir overuse at a Chicago hospital during the 2009 influenza pandemic and the poor predictive value of influenza-like illness criteria.Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis.

P2860

Q21089768-1E91729E-51BE-4C37-BEEB-D30474BC841B Q21135459-47A54FAF-E378-45E6-896B-527E2C576779 Q21261835-15743DD5-8486-4DE9-B6B7-212721FD25A5 Q21562135-C4D6A5E3-810F-4560-B6E9-FAF721D93802 Q24286924-22C47794-B5FB-4DDC-BD3B-FB14BF1CBB21 Q27013442-12EF75D4-C156-4C04-83F0-D9840E8233C6 Q27027408-09929308-A23E-493B-BCF5-361F0F5DC67B Q27307203-B19DB85E-791A-44AE-AC86-DCE9E38A69C6 Q27336337-981CC8AC-CF95-45D1-BF14-7645D77F54E8 Q27673887-88989346-2082-40D3-A2B8-9233C2676478 Q28292279-9B5C4154-741B-4061-9A90-82CF6B0759BF Q28474889-312FE403-4FB6-4CFA-A552-8770BCF5D782 Q28475628-6B83588F-C0D3-4160-B355-06AED17BF001 Q28478637-D0EA4533-B4ED-4952-B50E-4EAB2F196AE6 Q28541953-683E584F-FB96-4D3A-898F-BE1E6A18E5E2 Q30227284-E2A0B672-75C1-44D8-AE60-A6EE6E58E7C4 Q30234600-2712E56F-14FC-4CEB-BE33-839900929418 Q30352557-AA9D192E-6E8C-479E-9E7B-34389B5D76D2 Q30356466-85B7A4E5-610F-42B5-8F8B-264720A20B4E Q30363190-D30AD713-7924-4EC4-A860-02C41EA45C26 Q30366818-19E19AD6-AB3D-4BC6-9F76-BEB5373EB3C8 Q30367631-919BD7F0-A875-47D5-8DFD-5317481A55C4 Q30377007-F5AE6705-BA5A-4964-B929-2E3F6F7464A0 Q30379353-F9FEF144-F89C-4A90-A640-84B8B4A416E1 Q30379476-977CB81B-FEFB-4794-9453-87BA9B0349A4 Q30383194-B72D775B-3250-45D0-AA9A-1187D4BC4120 Q30386485-21CFA005-A059-4CEA-BFD9-EB8CCC4C5B4E Q30391856-3C42E296-72C7-4C4D-8989-D8A4568CC580 Q30392964-5C107256-2BAF-4930-8F32-BA75BD8B164B Q30393969-FF1D5AC9-594B-4131-9222-94D0FB12F880 Q30394067-453C9E88-8431-4D5F-B603-72DB9050E2BF Q30394366-D26FFE48-ED01-4CFE-9D08-6ACEC96F8F01 Q30396361-59F36035-28B1-485E-815B-3A051BD87037 Q30399321-00A93677-7E2F-474C-AFE2-63B7D77ADA60 Q30401070-C9B9583D-A4A5-4DF0-917D-951929CFAFE1 Q30407925-FC82A316-3D20-488A-9511-2E795870BCF8 Q30408105-DEDEF3BD-5A1E-4DD6-B660-4A0CA5B4D90F Q30408617-EF62BA70-9BC4-47D7-8A26-3CF7D9195F57 Q30409023-165C8A01-2F91-4FB1-88E6-61982966320C Q30409553-89900220-AC63-40DA-8032-A11F367F27F1

P2860

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

http://www.wikidata.org/entity/Q30374740

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

@ast

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

@en

type

label

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

@ast

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

@en

prefLabel

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

@ast

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

@en

P1433

Q30374740-2479B357-1956-4BB6-B32B-775D893C7591

P1476

Q30374740-21D59725-C2D2-4ED7-8DD1-936E8FAD55B1

P2093

Q30374740-0B7C63A0-5A4A-4FAC-BE3B-EDE7AE3DEC23

Q30374740-1152566D-6919-4488-AEFD-FEABDC05F3AF

Q30374740-49CCA2B8-3013-4BF0-ACAA-4D747FE93C94

Q30374740-DBE8B099-B091-4183-900C-D12EABCB6851

P2860

Q30374740-16294F02-710E-4F25-AEDC-174EC2293923

Q30374740-36D5704C-E3A0-45DF-8A32-03CF27CDD12A

Q30374740-3F12C26E-1F93-43B0-9366-98EA1579C61D

Q30374740-4D72AD6E-C259-4BC5-B5D2-5E8A83A85F53

Q30374740-876BE6AB-14C0-4A93-83CA-F0E4D89FFAC0

Q30374740-882C4F83-AAF6-46DD-A3E7-908ECA0F81BF

Q30374740-9491296A-ACFE-4300-AE8D-B2C527D42DF1

Q30374740-96D2AB68-1C54-45BD-B2BA-A4512DD1F426

Q30374740-AE1B3A98-1CC3-4367-B7B0-50CD26039157

Q30374740-B8BFEEEB-2FFA-40E7-88FF-CDD5772EEA62

P304

Q30374740-5F8A3D30-57BD-4985-83D8-498133F48B7F

P31

Q30374740-5659F986-14C2-4D2F-BE75-E3D72CA75429

P356

Q30374740-FAC3F468-8393-4F66-B42D-4C122CEAF8DE

P433

Q30374740-CF64FA04-8999-45DC-AC66-AD158FE066C5

P478

Q30374740-F1296EA6-EBCD-4021-8748-C8BD4007D5DA

P50

Q30374740-EFD02B38-619C-4480-B307-D6A79A8B0CEA

P577

Q30374740-AD4BA142-ACD5-43BE-B0BD-CEB4D0970CCE

P5875

Q30374740-C10A4068-A6EF-45A8-A062-04E3ED3CB55C

P698

Q30374740-D2EBDC39-349E-4C5E-9CFB-4450D6069EF6

P932

Q30374740-576D3BC0-3C31-4552-851A-91FA4DBE1012

P356

P1433

Emerging Infectious Diseases

P1476

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

@en

P2093

Angie Lackenby

http://www.w3.org/2001/XMLSchema#string

Katrine Borgen

http://www.w3.org/2001/XMLSchema#string

Olav Hungnes

http://www.w3.org/2001/XMLSchema#string

Siri H Hauge

http://www.w3.org/2001/XMLSchema#string

P2860

Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene.

Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.

Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies.

Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors.

Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.

Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.

Position statement: global neuraminidase inhibitor susceptibility network.

The global circulation of seasonal influenza A (H3N2) viruses.

P304

155-162

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID1502.081031

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Susanne Gjeruldsen Dudman

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237261592

http://www.w3.org/2001/XMLSchema#string

P698

19193257

http://www.w3.org/2001/XMLSchema#string

P932

2657637

http://www.w3.org/2001/XMLSchema#string